news
Heart and metabolic diseases are not separate issues, says Lancet
An editorial in *The Lancet* challenges the current medical practice of treating cardiometabolic diseases like obesity, type 2 diabetes, and heart failure as distinct conditions. It argues these issues are deeply linked by common pathways like insulin resistance and inflammation. This means managing them individually misses the bigger picture, pushing for a more integrated approach to care.
An editorial in The Lancet challenges the current medical practice of treating cardiometabolic diseases like obesity, type 2 diabetes, and heart failure as distinct conditions. It argues these issues are deeply linked by common pathways like insulin resistance and inflammation. This means managing them individually misses the bigger picture, pushing for a more integrated approach to care.
The architecture take
The medical system finally, officially, admits what you've likely felt in your own body: your glucose doesn't live in a silo separate from your heart. For years, we've had doctors specializing in one organ, often missing the cascading effects across your entire system. This Lancet editorial is a big deal because it signals a shift in how medical gatekeepers are thinking about complex, intertwined conditions. It's a shout-out to insulin resistance, inflammation, and adiposity as the master puppeteers, not just singular symptoms. What to watch: if this translates into actual integrated care models or if it just becomes another talking point without changing how clinics operate. My bet is on slow change, but the conversation has started. You, though, don't need permission to connect the dots: everything truly is connected.